J&K&L HC: Delay in Executing Preventive Detention on Unsubstantiated Medical Ground Makes it Invalid  ||  Delhi HC Allows AITA Results For Interim Management and Directs Fresh Elections Under New Sports Law  ||  J&K&L HC: Preventive Detention U/S 129 BNSS During Proceedings Must Satisfy Strict Legal Standards  ||  Gujarat HC: Firing in Air at a Wedding Without Intent to Harm Does Not Amount to Attempt to Murder  ||  Bom HC: Developers’ Profit Rights in Redevelopment Cannot Override Members’ Right to Safe Housing  ||  Supreme Court: Joint Accused Statements are Admissible Only When They Result in Distinct Discoveries  ||  SC to Ex-MLA in Money Laundering Case: Duped Homebuyer Must be Safeguarded First, then Consider Bail  ||  Supreme Court: Right to a Speedy Trial Cannot Override NDPS Act Bail Conditions  ||  SC: Relatives Cannot be Implicated in Bigamy Solely Based on Knowledge of a Second Marriage  ||  Supreme Court: Service Inam Land Attached to a Mosque Constitutes Waqf Property and is Inalienable    

U.S. PTO Rules in Favour of Mylan - (29 Aug 2016)

U.S.Patent and Trademark Office (PTO) has ruled in the favour of Natco Pharma’s marketing partner Mylan, with regard to patent claims pertaining to multiple sclerosis drug Copaxone.

Tags : U.S.PATENT AND TRADEMARK OFFICE   NATCO PHARMA   PATENT CLAIMS  

Share :        

Disclaimer | Copyright 2026 - All Rights Reserved